health equity

Sepsis Opportunities: Lessons from the COVID-19 Pandemic

Sepsis is the body’s extreme response to an infection. It is a life-threatening medical emergency. Sepsis happens when an infection you already have triggers a chain reaction throughout your body. Infections that lead to sepsis most often start in the lung, urinary tract, skin, or gastrointestinal tract. Without timely treatment, sepsis can rapidly lead to …

Sepsis Opportunities: Lessons from the COVID-19 Pandemic Read More »

Selfish Much?

By KIM BELLARD In a week where we’ve seen the bungled Afghan withdrawal, had Texas show us its contempt for all sorts of rights, watched wildfires ravage the west and Ida wreak havoc on a third of the country, and, of course, witnessed COVID-19 continue its resurgence, I managed to find an article that depressed …

Selfish Much? Read More »

AMA Forms External Advisory Group to Advance Equity in Healthcare Innovation

What You Should Know: – The American Medical Association (AMA) today announced the creation of an external advisory group, the Equity and Innovation Advisory Group dedicated to advance equity in healthcare innovation. – The advisory group plans to recommend strategies that will help drive equitable resources to health solutions created by marginalized innovators and include …

AMA Forms External Advisory Group to Advance Equity in Healthcare Innovation Read More »

Cerner Launches Social Determinants of Health Solution to Advance Health Equity

What You Should Know: – Cerner today announced a new solution, Cerner Determinants of Health, designed to help providers address healthcare inequities. – Cerner Determinants of Health is a dashboard and supporting set of tools, integrated into the Cerner electronic health record, to help clinicians pinpoint disparities and suggest goals and resources within the patient’s care plan …

Cerner Launches Social Determinants of Health Solution to Advance Health Equity Read More »

Build back better: US pharma and the future of healthcare

America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, and equitable health care system for all. COVID-19 highlighted both the challenges of the US healthcare system and the huge change potential of the country’s pharmaceutical industry. Now, as vaccination continues at pace, the sector has pledged …

Build back better: US pharma and the future of healthcare Read More »

Build back better: US pharma and the future of healthcare

America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, and equitable health care system for all. COVID-19 highlighted both the challenges of the US healthcare system and the huge change potential of the country’s pharmaceutical industry. Now, as vaccination continues at pace, the sector has pledged …

Build back better: US pharma and the future of healthcare Read More »

State Farm Taps Included Health to Improve Healthcare Equity for LGBTQ+ Employees

What You Should Know: – Today,  State Farm announced that it is elevating care for LGBTQ+ employees through a new partnership with Included Health. As a free healthcare benefit, State Farm employees and their families now have access to a dedicated care coordinator who can help them find supportive, affirming healthcare providers and navigate healthcare challenges.   – Discrimination is rampant …

State Farm Taps Included Health to Improve Healthcare Equity for LGBTQ+ Employees Read More »

INVEST Precision Medicine Conference Video: How Can We Improve Health Equity in Precision Medicine?

Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?

Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends

The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.

Watch: Building trust and enhancing clinical trial diversity

On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA Chief Operating Officer Lori Reilly and Genentech Vice President and Chief Diversity Officer Quita Highsmith discussed how to build greater trust among underserved communities, including communities of color, and how the industry is working to increase clinical …

Watch: Building trust and enhancing clinical trial diversity Read More »

More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities

We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients, including those in underserved communities. Health disparities are not new, but the COVID-19 pandemic put a spotlight on long-standing health inequities that affect diverse racial and ethnic communities …

More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities Read More »

More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities

We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients, including those in underserved communities. Health disparities are not new, but the COVID-19 pandemic put a spotlight on long-standing health inequities that affect diverse racial and ethnic communities …

More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities Read More »

PhRMA hosts first public workshop on clinical trial diversity

This week, 500+ health care and community members from over 150 organizations came together at PhRMA’s first stakeholder workshop focused on improving diversity in clinical trials. At the virtual workshop, titled “Partnering for Health Equity: Advancing Research Through Representative Clinical Trials,” participants joined breakout discussions, panels and facilitated conversations designed to pressure test actionable ideas …

PhRMA hosts first public workshop on clinical trial diversity Read More »

Hit hard by the pandemic, one California county looks to vaccinate its most vulnerable

Often overshadowed by its larger, more affluent neighbors to the west, Imperial County had few testing and vaccination resources early on. Now, flush with vaccines, groups in the county are taking targeted efforts to reach vulnerable communities.

Bias, Before First Breath

How structural racism and implicit bias impact America’s babies, even prior to birth By ELLIE STANG Becoming a new mother in America is more dangerous for some mothers than it should be. Each year, 700 women die in childbirth or from pregnancy-related causes in the United States, the highest number of any developed nation.  Health …

Bias, Before First Breath Read More »

NYC Health + Hospitals drops use of two race-based clinical assessments

The nation’s largest public health system will stop using clinical assessments for kidney function and vaginal delivery after C-sections that use race-based calculations for determining illness severity and risk. These assessments can result in people of color not receiving the diagnoses and treatments they need.

INVEST Video Conference: What is the role of AI in health equity? [Sponsored]

With artificial intelligence and machine learning algorithms are becoming more in vogue in different aspects of healthcare, our panel discusses how can we ensure that AI is leveraged properly so that it advances the goals of health equity.

Covid-19 and chronic disease: A spotlight and a stoplight 

Covid-19 has demonstrated the grave need for us to invest in chronic disease prevention and support by building stronger, deeper relationships with patients and families, and by focusing more on the environmental, social, and psychological factors that lead to chronic disease and impact long-term disease management.

In scramble to respond to Covid-19, hospitals turned to models with high risk of bias

Of 26 health systems surveyed by MedCity News, nearly half used automated tools to respond to the Covid-19 pandemic, but none of them were regulated. Even as some hospitals continued using these algorithms, experts cautioned against their use in high-stakes decisions.

Public health, racial equity, climate action drive Biden’s budget requests for healthcare

President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of Climate Change and Health Equity.

PhRMA member companies share how they are improving clinical trial diversity

As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our industry is developing potential best practices and key learnings that …

PhRMA member companies share how they are improving clinical trial diversity Read More »

Paper finds gaps in health data are a barrier to health equity

COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites. Similarly, the rate of COVID-19 related deaths among Black Americans and American Indian/Alaskan Natives are twice as high as whites. A recent PhRMA …

Paper finds gaps in health data are a barrier to health equity Read More »

New research shows hotspots of inequity relate to increased COVID-19 hospitalizations

As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer show that boroughs in New York City with the lowest per-person income and lowest number of employer establishments had the highest COVID-19 mortality rates.

New report highlights biopharmaceutical industry’s commitment to D&I

Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace, in the communities in which they operate and in the patient communities in which they serve. The report examines the state of accelerating demographic changes and …

New report highlights biopharmaceutical industry’s commitment to D&I Read More »

Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US

This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside of the novel coronavirus, major social issues have been brought to the forefront of public discourse. We understand that systematic racism is as real as any …

Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US Read More »

PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence

Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic racism is a disease. As a pharmacist and public health researcher whose motivation stems from advancing health equity – …

PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence Read More »

Why prioritizing health equity in the Covid-19 vaccine distribution is not just right, but necessary

Even though Covid-19 is distinct from any health crisis the country has previously faced, assessing U.S. public health strategies during past crises can provide insight into what has contributed to a more or less equitable response.

Guest Post: Honoring Hispanic Heritage Month by taking action on health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. Today, we are pleased to welcome a guest post from Jason Resendez who is the executive director of the UsAgainstAlzheimer’s Center for Brain Health Equity and head of the LatinosAgainstAlzheimer’s Coalition, …

Guest Post: Honoring Hispanic Heritage Month by taking action on health equity Read More »

Sharing rebates can improve access to medicines and increase health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Dr. Leah …

Sharing rebates can improve access to medicines and increase health equity Read More »

We’ve failed in chronic care management It’s time to change course.

In rearchitecting the system by training every care provider in every specialty, and enable lower-cost providers and communities, we will provide a new model of care where a physician isn’t the person who helps us when we’re sick — they help us be healthy.

Guest Post: Amgen Foundation stands for equal opportunities in STEM learning

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Eduardo Cetlin, …

Guest Post: Amgen Foundation stands for equal opportunities in STEM learning Read More »

Systemic racism is as real as any disease, and our industry is not immune

This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public declaration is an important milestone for our industry as we continue to take concrete steps to address systemic racism and work towards a more equitable …

Systemic racism is as real as any disease, and our industry is not immune Read More »

Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Jay Brown, …

Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month Read More »